Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Encompass Health Corporation (EHC:NYSE), powered by AI.
Encompass Health Corporation is currently trading at $101.47. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Encompass Health Corporation on Alpha Lenz.
Encompass Health Corporation's P/E ratio is 18.0.
“Encompass Health Corporation trades at a P/E of 18.0 (fair value) with strong ROE of 25.1%. 3Y revenue CAGR of 10.9% highlights clear growth momentum.”
Ask for details →Encompass Health Corporation is a prominent American healthcare services company specializing in providing facility-based and home-based post-acute healthcare services. The organization operates through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies across the United States. Encompass Health is dedicated to delivering high-quality, cost-effective care focused on enhancing patient outcomes following severe illnesses, surgeries, or injuries. The company plays a crucial role in the healthcare sector, particularly in rehabilitation and post-acute care, addressing the growing demand for comprehensive recovery solutions. Encompass Health Corporation is integral to the healthcare market, ensuring seamless patient transitions from hospital settings to recovery and long-term care, thereby contributing to the overall efficiency and modernization of the healthcare delivery system.
“Encompass Health Corporation trades at a P/E of 18.0 (fair value) with strong ROE of 25.1%. 3Y revenue CAGR of 10.9% highlights clear growth momentum.”
Ask for details →Encompass Health Corporation (ticker: EHC) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 28,678 employees. Market cap is $10.2B.
The current price is $101.47 with a P/E ratio of 18.01x and P/B of 4.18x.
ROE is 25.14% and operating margin is 17.74%. Annual revenue is $5.9B.